Regierung Von Oberbayern
UNION FORMAT FOR A WHOLESALE DISTRIBUTION AUTHORISATION
1. Authorisation Number
:
DE_BY_04_WDA_2024/ROB-55Ph-2678.Ph_3-122-55-6
2. Name of Authorisation Holder
ilapo Internationale Ludwigs-Arzneimittel GmbH & Co. KG
(ORG-100038386 / LOC-100060372)
3. Address(es) of Site(s)
Friedenheimer Bruecke 21, Neuhausen-Nymphenburg, Munich, Bavaria, 80639, Germany
4. Legally registered address of Authorisation Holder
Friedenheimer Bruecke 21, Neuhausen-Nymphenburg, Munich, Bavaria, 80639
5. Scope of authorisation
ANNEX 1
6. Legal basis of authorisation
Art. 77(1) of Directive 2001/83/EC
7. Name of responsible officer of the competent authority of the member state granting the wholesale distribution authorisation
Confidential, Confidential
8. Signature
9. Date
2024-04-22
10. Annexes attached
Annex 1 Scope of wholesale distribution authorisation
Annex 2 (Optional) Address(es) of contract wholesale distribution sites and their authorisation number
Annex 3 (Optional) Name(s) of responsible person(s)
Annex 4 (Optional) Date of Inspection on which authorisation was granted
Annex 5 (Optional) Additional provisions based on national requirements
SCOPE OF WHOLESALE DISTRIBUTION AUTHORISATION
Name and address of the site: ilapo Internationale Ludwigs-Arzneimittel GmbH & Co. KG
, Friedenheimer Bruecke 21, Neuhausen-Nymphenburg, Munich, Bavaria, 80639, Germany
Human medicinal products
1.1. with a Marketing Authorisation or registration in EEA country(s)
1.2. without a Marketing Authorisation or registration in the EEA and intended for EEA market*
1.3. without a Marketing Authorisation or registration in the EEA and intended for exportation
2.1. Procurement
2.2. Holding
2.3. Supply
2.4. Export
2.5. Other activities(s): (please specify) Activities within the scope of Section 73 para. 2 nos. 2, 2a, 3, 3a, para. 3 AMG, drop shipments
3.1. Narcotic or psychotropic products**
3.2. Products requiring low temperature handling
3.2.1. Temperatures between 2 to 8 °C
3.3. Other products: (please specify here or make a reference to Annex 5) Medicines derived from blood, Immunological medicines, Medicines requiring refrigeration
*Art. 5 of Directive 2001/83/EC, Art. 83 of Regulation (EC) 726/2004 and Art. 110 of Regulation 2019/6.
**Without prejudice to further authorisations as may be required according to national legislation.
Union Format for a Wholesale Distribution Authorisation
Page 1
Loading, please wait